Farhad Ravandi

Farhad Ravandi

UNVERIFIED PROFILE

Are you Farhad Ravandi?   Register this Author

Register author
Farhad Ravandi

Farhad Ravandi

Publications by authors named "Farhad Ravandi"

Are you Farhad Ravandi?   Register this Author

100Publications

2402Reads

23Profile Views

Moxetumomab pasudotox for the treatment of relapsed and/or refractory hairy cell leukemia.

Expert Rev Hematol 2019 Sep 1;12(9):707-714. Epub 2019 Aug 1.

Department of leukemia, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1643231DOI Listing
September 2019

Quizartinib in the treatment of FLT3-internal-tandem duplication-positive acute myeloid leukemia.

Future Oncol 2019 Sep 27. Epub 2019 Sep 27.

Department of Leukemia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0428 Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0353DOI Listing
September 2019

First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL).

Leuk Lymphoma 2019 Sep 30:1-5. Epub 2019 Sep 30.

Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1660967DOI Listing
September 2019

inhibitor quizartinib (AC220).

Leuk Lymphoma 2019 Aug 18;60(8):1866-1876. Epub 2019 Apr 18.

a Department of Leukemia , University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1602263DOI Listing
August 2019

How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?

Haematologica 2019 Aug 4;104(8):1532-1541. Epub 2019 Jul 4.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.208454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669140PMC
August 2019

Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia.

Ther Adv Hematol 2019 19;10:2040620719849496. Epub 2019 May 19.

Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719849496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535741PMC
May 2019

10-day vs 5-day decitabine: equivalence cannot be concluded - Authors' reply.

Lancet Haematol 2019 04;6(4):e178

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30052-3DOI Listing
April 2019

Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation.

J Clin Pathol 2019 Mar 22;72(3):251-257. Epub 2018 Nov 22.

Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2018-205399DOI Listing
March 2019

Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia.

Ther Adv Hematol 2019 15;10:2040620719827310. Epub 2019 Feb 15.

Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719827310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378516PMC
February 2019

How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:
Farhad Ravandi

Blood 2019 01 15;133(2):130-136. Epub 2018 Nov 15.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2018-08
Publisher Site
http://dx.doi.org/10.1182/blood-2018-08-832105DOI Listing
January 2019

Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Curr Treat Options Oncol 2019 01 24;20(1). Epub 2019 Jan 24.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 0428, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-019-0603-z
Publisher Site
http://dx.doi.org/10.1007/s11864-019-0603-zDOI Listing
January 2019

Is it time to routinely incorporate MRD into practice?

Authors:
Farhad Ravandi

Best Pract Res Clin Haematol 2018 12 21;31(4):396-400. Epub 2018 Sep 21.

Department of Leukemia, The University of Texas - M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.09.013DOI Listing
December 2018

Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience.

Mod Pathol 2018 11 28;31(11):1717-1732. Epub 2018 Jun 28.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0093-8DOI Listing
November 2018

Prognostic significance of hyperdiploidy in adult acute myeloid leukemia.

Am J Hematol 2018 11 9;93(11):E357-E360. Epub 2018 Sep 9.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25240DOI Listing
November 2018

Treatment of Acute Promyelocytic Leukemia With No or Minimal Chemotherapy: Now a Reality in Common Clinical Practice.

Authors:
Farhad Ravandi

J Oncol Pract 2018 11;14(11):663-664

The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00537DOI Listing
November 2018

FLT3 inhibitors in acute myeloid leukemia: Choosing the best when the optimal does not exist.

Am J Hematol 2018 08 25;93(4):553-563. Epub 2018 Jan 25.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25027DOI Listing
August 2018

Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.

J Clin Oncol 2018 06 27;36(18):1788-1797. Epub 2018 Apr 27.

Kiyomi Morita, Hagop M. Kantarjian, Feng Wang, Yuanqing Yan, Carlos Bueso-Ramos, Koji Sasaki, Ghayas C. Issa, Sa Wang, Jeffrey Jorgensen, Xingzhi Song, Jianhua Zhang, Samantha Tippen, Rebecca Thornton, Marcus Coyle, Latasha Little, Curtis Gumbs, Naveen Pemmaraju, Naval Daver, Courtney D. DiNardo, Marina Konopleva, Michael Andreeff, Farhad Ravandi, Jorge E. Cortes, Tapan Kadia, Elias Jabbour, Guillermo Garcia-Manero, Keyur P. Patel, P. Andrew Futreal, and Koichi Takahash, The University of Texas MD Anderson Cancer Center, Houston, TX; Kiyomi Morita, The University of Tokyo, Tokyo; and Koichi Takahashi, Kyoto University, Kyoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.6757DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008108PMC
June 2018

Evaluating measurable residual disease in acute myeloid leukemia.

Blood Adv 2018 06;2(11):1356-1366

Department of Clinical Immunology, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018016378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998930PMC
June 2018

MRD in HCL: does it matter?

Authors:
Farhad Ravandi

Blood 2018 05;131(21):2277-2278

University of Texas MD Anderson Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-04-843128DOI Listing
May 2018

Novel Therapies for Older Adults With Acute Lymphoblastic Leukemia.

Curr Hematol Malig Rep 2018 04;13(2):91-99

Department of Leukemia, Unit 428, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-018-0440-3DOI Listing
April 2018

Immune therapies in acute myeloid leukemia: a focus on monoclonal antibodies and immune checkpoint inhibitors.

Curr Opin Hematol 2018 03;25(2):136-145

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000401DOI Listing
March 2018

Current paradigms in the management of Philadelphia chromosome positive acute lymphoblastic leukemia in adults.

Am J Hematol 2018 Feb 31;93(2):286-295. Epub 2017 Oct 31.

Leukemia department, University of Texas, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24926DOI Listing
February 2018

Outcomes of Patients With Relapsed Core Binding Factor-Positive Acute Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2018 01 25;18(1):e19-e25. Epub 2017 Sep 25.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.09.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861376PMC
January 2018

Current management of Philadelphia chromosome positive ALL and the role of stem cell transplantation.

Authors:
Farhad Ravandi

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):22-27

Department of Leukemia, University of Texas-MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2017.1.22DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142602PMC
December 2017

A mind map for managing minimal residual disease in acute myeloid leukemia.

Clin Adv Hematol Oncol 2017 Nov;15(11):859-867

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
November 2017

Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?

Best Pract Res Clin Haematol 2017 09 15;30(3):193-200. Epub 2017 Jun 15.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2017.05.001DOI Listing
September 2017